Great to see Roth Capital initiate coverage of FTE today with a PT of $35.
I had blown out most of my position in this when I saw in the 10Q that they sold 807K shares privately last quarter at a price of just $6.73 per share. That just didn't sit right with me, that's about a 15% increase of shares outstanding, at a massive discount to the publicly traded stock price. I guess Roth either didn't pick up on that or did but chose to ignore it.
I'll stick with my remaining small FTE position at this point, now that they got some analyst coverage. Hopefully they refrain from issuing any more shares at huge discounts. Most of the funds from the sale of this stock went into an intriguing microcap medical device company called Milestone Scientific (MLSS), you should check them out.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.